While the Cu IUD represents the first line reversible contraception in women with breast cancer, concurrent medical issues such as endometrial proliferation on tamoxifen, anemia, menorrhagia, and dysmenorrhea may warrant consideration of local progestin therapy, especially in women with hormone receptor negative tumor types <a href=
http://tadalafi.sbs>cheap cialis generic online</a> Gynecol Obstet Investig 35 62 64